5,334
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Potential combination topical therapy of anal fissure: development, evaluation, and clinical study†

ORCID Icon, , &
Pages 1672-1682 | Received 05 Jun 2018, Accepted 29 Jul 2018, Published online: 15 Nov 2018

References

  • Agrawal V, Kaushal G, Gupta R. (2013). Randomized controlled pilot trial of nifedipine as oral therapy vs. topical application in the treatment of fissure-in-ano. Am J Surg 206:748–51.
  • Aman W, Thoma K. (2003). ICH guideline for photostability testing: aspects and directions for use. Pharmazie 58:877–80.
  • Arafa MG, Ayoub BM. (2017). DOE Optimization of nano-based carrier of pregabalin as hydrogel: new therapeutic; chemometric approaches for controlled drug delivery systems. Sci Rep 7:41503.
  • B.P. (British Pharmacopoeia Commission). (2010). British pharmacopeia. Vol. III, 6th ed. London: The Council of Europe, The Stationary Office, 3155–7.
  • Beaty JS, Shashidharan M. (2016). Anal fissure. Clin Colon Rectal Surg 29:30–7.
  • Bei D, Zhang T, Murowchick JB, Youan BB. (2010). Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization. AAPS Pharm 11:1243–9.
  • Botha SA, Lötter AP. (1990). Compatibility study between naproxen and tablet excipients using differential scanning calorimetry. Drug Dev Ind Pharm 16:673–83.
  • Bulus H, Varol N, Tas A, Coskun A. (2013). Comparison of topical isosorbide mononitrate, topical diltiazem, and their combination in the treatment of chronic anal fissure. Asian J Surg 36:165–9.
  • Byrne J, Wyraz A, Velasco-Torrijos T, Reinhardt R. (2017). Formulation factors affecting the isomerization rate of betamethasone-17-valerate in a developmental hydrophilic cream–a HPLC and microscopy based stability study. Pharm Dev Technol 22:537–44.
  • Collins SL, Moore RA, Mcquay HJ. (1997). The visual analogue pain intensity scale: what is moderate pain in millimetres? Pain 72:95–7.
  • Das B, Nayak AK, Nanda U. (2013). Topical gels of lidocaine HCl using cashew gum and Carbopol 940: preparation and in vitro skin permeation. Int J Biol Macromol 62:514–7.
  • Denyer S, Hodges N. (2004). Sterilization procedures and sterility assurance. In: Denyer SP, Hodges NA, Gorman SP, editors. Hugo & russell’s-pharmaceutical microbiology. 7th ed. Hoboken (NJ): Blackwell Science, 346–75.
  • Eggleston ST, Lush LW. (1996). Understanding allergic reactions to local anesthetics. Ann Pharmacother 30:851–7.
  • El-Leithy ES, Shaker DS, Ghorab MK, Abdel-Rashid RS. (2010). Evaluation of mucoadhesive hydrogels loaded with diclofenac sodium-chitosan microspheres for rectal administration. AAPS Pharm 11:1695–702.
  • Garg T, Rath G, Goyal AK. (2015). Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv 22:969–87.
  • Hall G, Kann BR. (2016). Anal fissure. Anorectal disease. Berlin, Germany: Springer, 95–126.
  • Haq Z, Rahman M, Chowdhury R, et al. (2005). Chemical sphincterotomy-first line of treatment for chronic anal fissure. Mymensingh Med J 14:88–90.
  • Havlickova B. (2010). Topical corticosteroid therapy in proctology indications. Aliment Pharm Ther 31:19–32.
  • Higuchi T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145–9.
  • Hooda A, Nanda A, Jain M, et al. (2012). Optimization and evaluation of gastroretentive ranitidine HCl microspheres by using design expert software. Int J Biol Macromol 51:691–700.
  • Khunt DM, Mishra AD, Shah DR. (2012). Formulation design & development of piroxicam emulgel. Int J Pharmtech Res 4:1332–44.
  • Late S, Banga A. (2008). Thermal and non-thermal methods to evaluate compatibility of granisetron hydrochloride with tablet excipients. Pharmazie 63:453–8.
  • Lira A, Araújo A, Basílio I, et al. (2007). Compatibility studies of lapachol with pharmaceutical excipients for the development of topical formulations. Thermochim Acta 457:1–6.
  • Liu J, Cao F, Zhang C, Ping Q. (2013). Use of polymer combinations in the preparation of solid dispersions of a thermally unstable drug by hot-melt extrusion. Acta Pharm Sin B 3:263–72.
  • Lodén M, Åkerström U, Lindahl K, Berne B. (2005). Novel method for studying photolability of topical formulations: a case study of titanium dioxide stabilization of ketoprofen. J Pharm Sci 94:781–7.
  • Maafi W, Maafi M. (2013). Modelling nifedipine photodegradation, photostability and actinometric properties. Int J Pharm 456:153–64.
  • Martin AN, Bustamante P, Chun AHC. (1993). Physical pharmacy: physical chemical principles in the pharmaceutical sciences. 4th ed. Philadelphia: Lea & Febiger.
  • Moffat AC, Osselton MD, Widdop B, Watts J. (2011). Clarke’s analysis of drugs and poisons. 4th ed. London: Pharmaceutical Press.
  • Nagajyothi M, Pramod K, Bijin E, et al. (2015). Accelerated stability studies of atorvastatin loaded nanoemulsion gel. Asian J Pharm Technol 5:188–91.
  • Perrotti A, Bartone N, Stefano MD, et al. (2000). Topical Nifedipine® for conservative treatment of acute haemorrhoidal thrombosis. Colorectal Dis 2:18–21.
  • Perrotti P, Bove A, Antropoli C, et al. (2002). Topical nifedipine with lidocaine ointment vs. active control for treatment of chronic anal fissure: results of a prospective, randomized, double-blind study. Dis Colon Rectum 45:1468–75.
  • Ritger PL, Peppas NA. (1987). A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 5:23–36.
  • Rowe RC, Sheskey PJ, Quinn ME. (2009). Handbook of pharmaceutical excipients. 6th ed. Washington (DC): American Pharmaceutical Association.
  • Santis AK, De Freitas ZMF, Ricci-Junior E, et al. (2013). Nifedipine in semi-solid formulations for topical use in peripheral vascular disease: preparation, characterization, and permeation assay. Drug Dev Ind Pharm 39:1098–106.
  • Shenfield GM. (1982). Fixed combination drug therapy. Drugs 23:462–80.
  • Srivastava A, Wadhwa S, Ridhurkar D, Mishra B. (2005). Oral sustained delivery of atenolol from floating matrix tablets-formulation and in vitro evaluation. Drug Dev Ind Pharm 31:367–74.
  • Torsiello M, Kopacki M. (2000). Transdermal nifedipine for wound healing: case reports. Int J Pharm Compd 4:356–8.
  • Tsunoda A, Kashiwagura Y, Hirose KI, et al. (2012). Quality of life in patients with chronic anal fissure after topical treatment with diltiazem. World J Gastrointest Surg 4:251–5.
  • Verma RK, Garg S. (2005). Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing. J Pharm Biomed Anal 38:633–44.
  • Yang H, Zhu S, Pan N. (2004). Studying the mechanisms of titanium dioxide as ultraviolet-blocking additive for films and fabrics by an improved scheme. J Appl Polym Sci 92:3201–10.
  • Zimmermann J, Schlegelmilch R, Mazur D, et al. (2007). Proof of systemic safety of a lidocaine ointment in the treatment of patients with anorectal pain. Arzneimittelforschung 57:12–19.